GL1X · GenesisL1 explorer

Research workbench

KAPOSI'S sarcoma herpesvirus protease in complex with allosteric inhibitor

Analyse KAPOSI'S sarcoma herpesvirus protease in complex with allosteric inhibitor in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5UVP
Type
protein
Length
380 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Orf 17
UniProt
O40922
Ligands
8N7
Pockets
3 · best druggability 0.71

Structure

x-ray diffraction · 2 distinct chains · 32% helix, 28% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AOrf 17protein19032% helix, 28% strandO40922
BOrf 17protein19031% helix, 27% strandO40922

Ligands and binding sites

  • 8N7 · 6-(cyclohexylmethyl)-N-{2-[(oxan-4-yl)oxy]-4-(1H-tetrazol-5-yl)phenyl}pyridine-2-carboxamide · ligand · 3 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
17380.710.7769empty
21770.540.78218N7
3860.380.76148N7

Interfaces

1 interface between chains.

  • A–B · 760 Ų buried · 14 hydrogen bonds · protein-protein

Compared structures

  • 5UVP · Kaposi's Sarcoma Herpesvirus Protease in Complex with Allosteric Inhibitor · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.